ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2024-12-19  |  UPDATED: 1403/06/01 - 19:53:2 FA | AR | PS | EN
Talibans new law bans womens voices and faces             Iranian police shut down two illegal centers affiliated with German government             All of President Pezeshkians ministerial picks win parliaments vote of confidence             Wheres Bangladesh Heading after Popular Uprising?            Western Kabul residents say Taliban has failed to ensure security after bombing             Algerian Boxer Khelif files complaint over online harassment after gender row             Federalism in Afghanistan: Opportunities and Challenges             Formation of the Federalist Assembly of Afghanistan             Israel launches missile attack on outskirts of Damascus, killing Syrian civilians             UK national scandal: 20,000 mental health patients raped, sexually assaulted in NHS care             Three US troops killed, dozens injured in drone attack in Syria             Trump says NATO will not come to rescue if US attacked             Ukraine beset by $40m fraud in arms procurement amid war with Russia            US approves sale of F-16 jets to Turkey after Ankara ratifies Swedens NATO membership             UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza            


DATE PUBLISHED: 1399/02/17 - 15:06:0
VISIT: 1092
SHARE WITH YOUR FRIENDS

Will a coronavirus vaccine be accessible to everyone or only the privileged few?

In 2016, Dr Peter Hotez and his team were working on a coronavirus vaccine in Texas. The next step would have been to begin trials on people. Instead, he had to pull the plug due to a lack of interest - and funds.

In March this year Hotez, the co-director of the Center for Vaccine Development at Texas Childrens Hospital and Dean of the National School of Tropical Medicine in Houston, testified before the US House Committee on Science.

His teams vaccine had been created in response to the SARS outbreak over a decade earlier.

"We had the vaccine ready to go," Hotez told the committee. "But by then nobody was interested in a coronavirus vaccine."

"Twenty years have passed since the outbreak of SARS, yet the pharmaceutical industries havent considered infectious diseases a matter of priority because they are not as profitable as chronic diseases," Massimo Florio, professor of public economics at the University of Milan, told Euronews.

Analysis by Bloomberg intelligence has shown that the worlds 20 largest pharmaceutical companies operated around 400 new research projects over the past year. Roughly half were devoted to tackling cancer, while only 65 dealt with infectious diseases. Of those 20 big firms, only four had special vaccine units.

"The current research system is the victim of an incurable contradiction between the priority of science for health and that of science for profit," Professor Florio says.

The market sets the agenda

As countries around the world race to find a COVID-19 vaccine, governments and the European Union are being called upon to guarantee that once one becomes available, it will be accessible and economically affordable for all countries - even the poorest.

On April 17 the European Parliament passed a resolution insisting that "any publicly funded research" for a coronavirus vaccine "must stay in the public domain".

"This is a powerful statement," Belgian Green Party MEP Petra De Sutter told Euronews. "The idea that the market solves everything is fake. In a time of crisis, governments have to face the issue."

Before the resolution was voted, she was one of the signatories to a letter from a cross-party group to the European Commission, demanding urgent action to ensure the economic affordability of any COVID-19 vaccine funded by the European Union. The letter expressed alarm that no such provision had been included in publicly-funded research projects.

"The pharmaceutical one is not like a common industry. Its not about buying a new television set. Consumers have no choice when they are ill and in need of a specific drug," De Sutter explained.

"Right now, its the market that sets the agenda on the development of new drugs. Yet, the market would never invest in something that doesnt appear to be profitable. Moreover, some highly expensive drugs are developed also thanks to public funding. For this reason, we need to rethink a European-led research on health and drugs in accordance with peoples needs," De Sutter said.

Global project to ensure access to COVID-19 medical products

According to the World Health Organization, 62 research programmes are currently underway in laboratories around the world to find a vaccine for COVID-19.

Recently, Costa Rica asked the WHO to create a voluntary pool to collect patent rights, data and other information so as to widen access to medical products for combating the coronavirus.

In response, the world health body launched a global project named "Access to COVID-19 Tools Accelerator" to ensure worldwide access to resources, although the extent to which the project will include a pool to collect patent rights remains unclear.

In Europe, although there is a European Patent Office - whose monopoly patents generally last 20 years - each country independently negotiates the cost of a drug with the pharmaceutical industry.

In Germany, the Protection against Infection Act has been recently amended to give the Federal Health Ministry additional powers - including the competence to order limitations on patents - when the Bundestag finds there is an epidemic situation of national significance.

Outside the EU, Canada has amended its laws amid the COVID-19 emergency to gain easier access to compulsory licenses, a mechanism which enables governments to pay a set fee for an intellectual property without seeking the rights holders consent.

In the past, some developing countries used similar strategies to treat their citizens. In 1997 South Africa passed a Medicines Act to obtain patented HIV life-saving medicines from countries where they were sold more cheaply. At the time some of the worlds largest pharmaceutical companies took the South African government to the Pretoria High Court - before backing down in the face of overwhelming public pressure.

Danger of stark inequality in access to new COVID-19 treatments

On April 15 more than 20 organisations wrote to the UK government asking that any COVID-19 vaccine or treatment obtained with public funds be made available for all.

"Without such safeguards, there may be stark global inequality in access to new COVID-19 technologies, as was experienced during the H1N1 flu outbreak in 2009 where the wealthiest countries bought up most of the vaccines first," the letter says.

The patient campaign Just Treatment, which has been demanding fair access to medicines for years, is among those who signed the document. A year ago the group supported the campaign to made Orkambi, a drug to treat cystic fibrosis, available to all patients.

While today the deadlock has been resolved, at the time the NHS said it couldnt afford the high prices of the new drug to make it available. As a result, some parents of children with the disease clubbed set up a buyers club to buy a generic version of the medicine from Argentina at a more affordable price.

"We are facing a new wave of patent-protected drugs, mostly cancer drugs, at a very high price in the European market. We are likely to see monopolies leading to restrictions on access, based largely on price," Diarmaid McDonald, Just Treatments lead organiser, told Euronews.

"Right now, we have a global pandemic and the response also should be global. This is the moment to clear conditions about public funding."

Just Treatment supported also hepatitis C patients to obtain the drug they needed. "When Sofosbuvir came to the market, in 2015, the high price of the medicine had been a barrier to access it. The NHS rationed it so that the drug was immediately available only to the sickest patients: others were forced to wait for months and years to access the treatment," McDonald explained.

The entire system has to change

"This must not happen again," Simon Brasch, a Just Treatment leader and a former hepatitis C patient told Euronews. "I clearly remember I went through a medical examination to learn whether or not I could access the treatment. The doctor told me my liver hadnt deteriorated enough, so I had to wait. I couldnt believe it. I said to myself: maybe I should drink a couple of vodkas every night till my liver gets worse, so that finally I could be treated."

"Finally, I accessed the medicine, but what about the next expensive drug that wont be available in the future? Its the entire system of the pharmaceutical market that has to change," Brasch said.

Doctors Without Borders has also signed the letter to the UK government. Since 1999, when the NGO won the Nobel Peace Prize, it has been fighting for the affordability of medicines, through its "Access campaign". "We know too well from our work around the world what it means to not be able to treat people in our care because a needed drug is just too expensive or simply not available," the NGO said in a public statement.

A year ago, for the first time in Europe, Doctors Without Borders and other NGOs used a new humanitarian mechanism to vaccinate refugee children in Greece against pneumonia at an affordable price. Thanks to this mechanism the vaccine has a special reduced price of about US$9 (€8.23). Without that safeguard, the price of the vaccine in Greece would have been US$168 (€153.80) per child.

"While the ‘Humanitarian Mechanism has been useful in protecting children in crisis, countries at all income levels continue to struggle to access the pneumonia vaccine at an affordable price," the NGO said on a statement.

"Approximately one-third of countries globally have not been able to include the pneumonia vaccine in their standard vaccination package due to the exorbitant price charged by Pfizer and GSK," Doctors Without Borders announced, referring to the two pharmaceutical producers of the vaccine. "Pneumonia remains the single largest killer of children under five worldwide," the organisation went on to say.

According to a WHO report, in 2017 more than 800,000 children under five died due to pneumonia, accounting for 15% of all deaths of children in that age group.

An opportunity to rethink the rules

"The emergency we are experiencing must be an opportunity to rethink the rules that have defined the pharmaceutical market in recent decades," says Professor Massimo Florio of the University of Milan.

Various surveys have shown that in recent years pharmaceutical companies tend to invest only in the final stages of research when the profit appears assured, while the initial steps are carried out thanks to the resources of universities or associations.

"This pandemic highlights the failure of the current pharmaceutical market. For this we need a European public structure that produces the drugs that the private sector does not care about or that exist on the market only at exorbitant prices," Professor Florio says.

"Today we cant believe that developed countries like ours woke up without a vaccine and drugs to fight COVID-19, and even without masks. This must not happen again."

 

SOURCE: Euronews

LINK: https://www.ansarpress.com/english/17045


TAGS:






*
*

*



SEE ALSO

UK national scandal: 20,000 mental health patients raped, sexually assaulted in NHS care


US: 3 dead in shooting at Texas apartment complex


UN agency says over half a million Palestinians face catastrophic hunger in Gaza


Survivors of Russian charter flight crash transferred to Kabul


Pro-Israel lobby ousted ABC journalist, prompting staff to call for industrial action


UNICEF: Afghan earthquakes leave 100,000 children in urgent need of aid this winter


Thousands rage in Toronto against Israeli genocide as Gaza war marks 100 days


Thousands rally in front of White House to demand ceasefire in Gaza


Increased Taliban arrests lead to Kabul families restricting womens movement


Taliban arrests dozens of women in Kabul for improper hijab, says womens group





VIEWED
MOST DISCUSSED




POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

Sudan: The Forgotten War

Talibans new law bans womens voices and faces

Iranian police shut down two illegal centers affiliated with German government

All of President Pezeshkians ministerial picks win parliaments vote of confidence

Wheres Bangladesh Heading after Popular Uprising?

Western Kabul residents say Taliban has failed to ensure security after bombing

Algerian Boxer Khelif files complaint over online harassment after gender row

Federalism in Afghanistan: Opportunities and Challenges

Formation of the Federalist Assembly of Afghanistan

Israel launches missile attack on outskirts of Damascus, killing Syrian civilians

UK national scandal: 20,000 mental health patients raped, sexually assaulted in NHS care

Three US troops killed, dozens injured in drone attack in Syria

Trump says NATO will not come to rescue if US attacked

Ukraine beset by $40m fraud in arms procurement amid war with Russia

US approves sale of F-16 jets to Turkey after Ankara ratifies Swedens NATO membership

UNSC to meet to discuss ICJ ruling on Israeli genocide in Gaza

Taliban: Afghanistan Does Not Have Formal Border With Pakistan

Gazas major health facility collapses amid Israeli attacks: MSF

Americans to redeploy nuclear weapons in UK amid fears of WW3

Biden makes history: 1st sitting US president sued for complicity in genocide

Trump walks out of courtroom during closing arguments of Carrolls attorney

US: 3 dead in shooting at Texas apartment complex

US-UK aggression against Yemen risks expansion of war: Iran

Yemen directly hits US warship with ballistic missile

Hamas has self-reliantly opposed the three giant intelligence agencies of the world!

President Raeisi calls for UN reform, says body unable to end Gaza genocide

Pedram: The Abduction of Hazara and Tajik Women Recalls the Crimes of Abdur Rahman

Special envoys from G7 countries discuss Afghanistan in London meeting

Turkish lawmakers open debate over Swedens NATO membership

UN agency says over half a million Palestinians face catastrophic hunger in Gaza

Palestinian Islamic Jihad: Al-Maghazi operation proved defeat of Israeli regime in Gaza war

European support for Israel damaging energy security on the continent, report says

Pakistan Army Kills Seven Terrorists Near Afghan Border

Israel kills at least 190 people in Khan Younis in 24 hours

UNAMA report: 49 Hazara community members killed in Afghanistan in three months

Indias Modi inaugurates Hindu temple on site of razed mosque ahead of elections

US 2024 election: DeSantis drops out of Republican presidential race, backs Trump

Survivors of Russian charter flight crash transferred to Kabul

Irans anti-terror strikes clear message to certain recipients: Foreign Ministry

Ethnic mass killings in one Sudan city last year left up to 15,000 dead: UN report


MEDICAL NEWS


ANSAR PRESS  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. Ԑ یی